Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Idan Elmelech currently holds 14,495 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), valued at approximately $0. This represents their equity stake as COO & Principal Financial Ofcr.
Based on SEC Form 4 filings, Idan Elmelech has been a net neutral trader of BBOT stock. They have purchased $0 and sold $0 worth of shares.
Idan Elmelech's most recent insider trade was on Jul 1, 2026, when they sold 343 shares at $7.80 per share.
Idan Elmelech serves as COO & Principal Financial Ofcr at BridgeBio Oncology Therapeutics, Inc. (BBOT). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Idan Elmelech holds the position of COO & Principal Financial Ofcr at BridgeBio Oncology Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Idan Elmelech has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Idan Elmelech was on Jul 1, 2026, when they sold $2.7K worth of BBOT shares. This transaction involved 343 shares at $7.80 per share.
Idan Elmelech currently owns 14,495 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Idan Elmelech's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Idan Elmelech has 1 Form 4 filings on record as an insider at BridgeBio Oncology Therapeutics, Inc..
Set alerts for Idan Elmelech and 40,000+ other insiders.